Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harland

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Scientific Reports|June 22, 2019
High-Resolution Copy Number Patterns From Clinically Relevant FFPE MaterialAnastasia Filia, Alastair Droop, Mark Harland, et al.
Human Molecular Genetics|January 8, 2017
A population-based analysis of germline BAP1 mutations in melanomaSally J O'Shea, Carla Daniela Robles-Espinoza, Lauren McLellan, et al.
Pigment Cell & Melanoma Research|October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cellsMarina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Genes, Chromosomes & Cancer|February 9, 2010
Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanomaCaroline Conway, Samantha Beswick, Faye Elliott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention TrialJohn R Davies, Tracey Mell, Harriett Fuller, et al.
The Journal of Investigative Dermatology|July 8, 2014
Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclassJohan Staaf, Katja Harbst, Martin Lauss, et al.
Human Molecular Genetics|March 31, 2022
Defining novel causal SNPs and linked phenotypes at melanoma-associated lociCarolina Castaneda-Garcia, Vivek Iyer, Jérémie Nsengimana, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United KingdomJulia A Newton-Bishop, Yu-Mei Chang, Mark M Iles, et al.
Cancer Research|November 7, 2019
Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor ImmunitySathya Muralidhar, Anastasia Filia, Jérémie Nsengimana, et al.
Oncogene|April 28, 2005
A mutation hotspot at the p14ARF splice siteMark Harland, Claire F Taylor, Philip A Chambers, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Scientific Reports|June 22, 2019
High-Resolution Copy Number Patterns From Clinically Relevant FFPE MaterialAnastasia Filia, Alastair Droop, Mark Harland, et al.
Human Molecular Genetics|January 8, 2017
A population-based analysis of germline BAP1 mutations in melanomaSally J O'Shea, Carla Daniela Robles-Espinoza, Lauren McLellan, et al.
Pigment Cell & Melanoma Research|October 30, 2019
MX 2 is a novel regulator of cell cycle in melanoma cellsMarina Juraleviciute, Joanna Pozniak, Jérémie Nsengimana, et al.
Genes, Chromosomes & Cancer|February 9, 2010
Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanomaCaroline Conway, Samantha Beswick, Faye Elliott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2023
Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention TrialJohn R Davies, Tracey Mell, Harriett Fuller, et al.
The Journal of Investigative Dermatology|July 8, 2014
Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclassJohan Staaf, Katja Harbst, Martin Lauss, et al.
Human Molecular Genetics|March 31, 2022
Defining novel causal SNPs and linked phenotypes at melanoma-associated lociCarolina Castaneda-Garcia, Vivek Iyer, Jérémie Nsengimana, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United KingdomJulia A Newton-Bishop, Yu-Mei Chang, Mark M Iles, et al.
Cancer Research|November 7, 2019
Vitamin D-VDR Signaling Inhibits Wnt/β-Catenin-Mediated Melanoma Progression and Promotes Antitumor ImmunitySathya Muralidhar, Anastasia Filia, Jérémie Nsengimana, et al.
Oncogene|April 28, 2005
A mutation hotspot at the p14ARF splice siteMark Harland, Claire F Taylor, Philip A Chambers, et al.
Pageof 8